Head to head
IQVIA Holdings vs Thermo Fisher Scientific
Side-by-side on the measures that matter, with a plain-English read. Full detail: IQV · TMO
IQV
IQVIA Holdings
258.11-0.72%
1-year price shape — +29% over the period
Quant Rating C · 67/100
vs
TMO
Thermo Fisher Scientific
662.06+0.83%
1-year price shape — +23% over the period
Quant Rating C · 64/100
1-year performance, rebased to 100
Thermo Fisher Scientific edges it on the scoreable measures. Thermo Fisher Scientific pays the highest dividend yield; Thermo Fisher Scientific earns the most per share.
| IQV | TMO | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Diagnostics & Research |
| Last price | 258.11 | 662.06 |
| Change today | -0.72% | +0.83% |
| 1-year return | +28.5% | +23.1% |
| Market cap | $42.48B | $244.79B |
| 52-week range | 154.50 – 277.40 | 434.50 – 694.33 |
| Valuation | ||
| P/E (TTM) | 32.10 | 35.63 |
| P/E percentile, own 5-yr range | 55th | 86th |
| P/B | 6.88 | 4.65 |
| Dividend yield | 0.00% | 0.27% |
| Profitability & growth | ||
| EPS (TTM) | 7.84 | 17.74 |
| Net profit (TTM) | $1.29B | $6.56B |
| Revenue (TTM) | $16.98B | $46.34B |
| Revenue growth (YoY) | +8.7% | +10.5% |
| Gross margin | 33.0% | 40.8% |
| Operating margin | 13.9% | 18.3% |
| Net margin | 8.1% | 15.0% |
| Free cash flow (TTM) | $2.18B | $7.32B |
| Ownership & sentiment | ||
| Institutional ownership | 102.8% | 93.1% |
| Insider activity (12mo) | 36 buy / 14 sell | 22 buy / 28 sell |
| Short interest (% of float) | 2.5% | 1.4% |
| Analyst consensus | 93% buy / 7% hold (15) | 88% buy / 12% hold (17) |
| Analyst price target | $287 (+11%) | $653 (-1%) |
| StockVane view | ||
| StockVane Quant Rating | C (67) | C (64) |
| Company | ||
| Employees | 93,000 | 125,000 |
| Founded | 1950 | 1956 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.